# Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)

> **NCT03855228** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 704 (actual)

## Conditions studied

- Rhinitis, Allergic

## Interventions

- **DRUG:** Mometasone furoate nasal spray (MFNS)
- **DRUG:** Loratadine
- **DRUG:** Placebo nasal spray
- **DRUG:** Placebo tablet

## Key facts

- **NCT ID:** NCT03855228
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-03-01
- **Primary completion:** 1995-08-07
- **Final completion:** 1995-08-07
- **Target enrollment:** 704 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03855228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03855228, "Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03855228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*